Tests for cancer risks with recommendations for prevention and early detection

  • AnteBC – Breast Cancer

    AnteBC is an advanced genetic test that assesses a woman's personal risk of developing breast cancer using a polygenic risk score. Breast cancer is the most common cancer in women. The purpose of the AnteBC test is to reduce the risk of premature mortality due to breast cancer through advanced breast cancer screening and other preventive measures.

    Read more
  • AntePC – Prostate Cancer

    Prostate cancer is the most common malignancy in men. It mostly develops slowly but can be aggressive and metastasize to other parts of the body. AntePC is a unique test to elucidate personal prostate cancer genetic risk. The purpose of the AntePC test is to reduce the risk of premature mortality due to prostate cancer by more accurate screening.

    Read more
  • AnteCRC – Colorectal Cancer

    Colorectal cancer is a common malignancy of the digestive system with a poor prognosis and high morbidity and mortality rate. AnteCRC is a genetic test that measures the personal risk of developing colorectal cancer using a polygenic risk score. The purpose of the AnteCRC test is to reduce the risk of premature mortality due to colorectal cancer through primary prevention and more accurate screening.

    Read more
  • AnteMEL – Melanoma

    Melanoma is the most aggressive form of skin cancers. If diagnosed early, the disease is treatable. AnteMEL is a genetic test that assesses a personal risk of developing skin melanoma using a polygenic risk score, also giving individualized recommendations for risk management and screening. The purpose of the AnteMEL test is to reduce the risk of premature mortality due to melanoma through primary and secondary prevention measures.

    Read more